Mohammad-Hossein Yazdi

5PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersNanomedicineMolecular targetsChemotherapyCell physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
Umbelliprenin co-formulated with selenium nanoparticles downregulates MMP-2, MMP-9 and ICAM-1 expression in triple-negative breast cancer cells MDA-MB-231.

|Feb 27, 2026
Synergistic Immunoenhancement of Recombinant PBP2a Vaccine Candidate by Biogenic Selenium Nanoparticles and MF59 Against Methicillin-Resistant Staphylococcus Aureus.

Mahya Daneshpajooh Rahmani, Mohammad Hossein Yazdi, Setareh Haghighat

|Jan 21, 2023
Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review.

Mina Hosseini, Simin Seyedpour, Behzad Khodaei

|Apr 21, 2021
Effect of prevalent polychlorinated biphenyls (PCBs) food contaminant on the MCF7, LNCap and MDA-MB-231 cell lines viability and PON1 gene expression level: proposed model of binding.

Fatemeh Yazdi, Shahram Shoeibi, Mohammad Hossein Yazdi

|Apr 12, 2021
Comparison of Cytokine Expression in Human PBMCs Stimulated with Normal and Heat-Shocked Lactobacillus plantarum Cell Lysate.

Marzieh Sanaei, Mehdi Mahdavi, Neda Setayesh

Pageof 1

Frequent Collaborators

1 joint publications

Fatemeh Yazdi

1 joint publications

Shahram Shoeibi

1 joint publications

Akram Eidi

1 joint publications

Setareh Haghighat